Further, DATS treatment decreased the incidences of breast cancers in xenografted MDA-MB-231 tumor models via reducing MMP-2 and -9 expression levels (Wei et al., 2017; Liu et al., 2018; Vijayakumar et al., 2019). Here, MMP2 is linked to breast carcinoma.